Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2011-11-21Clinical Trial Update: Oxidative Stress Markers Evaluation Before and After Periodontal Treatment of Diabetics Type 2 Patients [EARLY_Phase 1]
A Phase 1 clinical trial from the University of Sao Paulo evaluating oxidative stress markers before and after periodontal treatment in adul…
-
CLINICAL_TRIALS trial_result · 2011-11-14Clinical Trial Update: Is There a Metabolic Effect of Cinnamon on HbA1c, Blood Pressure and Serum Lipids in Type 2 Diabetes Mellitus? [Phase 2]
A Phase 2 clinical trial update evaluating whether cinnamon affects HbA1c, blood pressure, and serum lipids in Type 2 Diabetes Mellitus. The…
-
CLINICAL_TRIALS trial_result · 2011-11-11Clinical Trial Update: Dose-Range Finding Study for MK0893 (0893-008) [Phase 2]
This Phase 2 dose-range finding trial of MK0893 (0893-008) in Type 2 diabetes was terminated. Results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-11-11Clinical Trial Update: Early Diabetes Intervention Program [Phase 4]
This is an update on a Phase 4 clinical trial called the Early Diabetes Intervention Program conducted by Indiana University School of Medic…
-
CLINICAL_TRIALS trial_result · 2011-11-11Clinical Trial Update: Effect of Pasta on Blood Glucose Response in Normal Subjects [NA]
A completed clinical trial evaluated how pasta consumption affects postprandial blood glucose in healthy adults. The study addresses implica…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-11-10Clinical Trial Update: Pharmacokinetics and Pharmacodynamics Trial With Linagliptin (BI 1356) 5mg in African American Type 2 Diabetic Patients [Phase 1]
Phase 1 pharmacokinetics and pharmacodynamics study of linagliptin (BI 1356) 5 mg in African American patients with Type 2 diabetes mellitus…
-
CLINICAL_TRIALS trial_result · 2011-11-10Clinical Trial Update: Effectiveness and Safety of Two Approaches to the Management of Type 2 Diabetes Mellitus in Australian Primary Care [Phase 4]
A Phase 4 clinical trial comparing two management approaches for Type 2 diabetes in Australian primary care was terminated; the update discu…
-
CLINICAL_TRIALS trial_result · 2011-11-10Clinical Trial Update: Metabolic Response to 3-day Fast Versus Carbohydrate-free Diet in Type 2 Diabetes [NA]
A completed clinical trial comparing metabolic responses to a 3-day fast versus a carbohydrate-free diet in adults with Type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2011-11-09Clinical Trial Update: Evaluation of Cissus Verticillata L. Infusion in Controlling Type 2 Diabetes [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluated a Cissus verticillata infusion for controlling Type 2 diabetes; the study has completed.
-
CLINICAL_TRIALS trial_result · 2011-11-09Clinical Trial Update: The Effect Of Glycemic Control On Malondialdehyde, Glutathione Peroxidase, Glutathione And Paraoxonase
A completed clinical trial evaluating the effects of glycemic control on oxidative stress biomarkers (malondialdehyde, glutathione peroxidas…
-
CLINICAL_TRIALS research · 2011-11-09Clinical Trial Update: The Effect of Roux-en-Y Gastric Bypass on Mitochondrial Function in Type 2 Diabetes
This clinical trial update investigates the effect of Roux-en-Y gastric bypass on mitochondrial function in people with Type 2 diabetes and …
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Effects of Amlodipine/Benazepril in the Hypertensive African-American Population With Type 2 Diabetes Mellitus [Phase 4]
Phase 4 clinical trial update evaluating the efficacy of the amlodipine/benazepril combination in hypertensive African-American patients wit…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes Mellitus [Phase 4]
Phase 4 trial evaluating whether valsartan reduces proteinuria in patients with hypertension and type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Effects of Exercise Intervention and Rehabilitation Exercise Intervention in Patients With Type 2 Diabetes [NA]
A clinical trial update reports the completion of a study evaluating exercise interventions in adults with Type 2 Diabetes Mellitus.
-
CLINICAL_TRIALS trial_result · 2011-11-07Clinical Trial Update: A Local Experiential Study With Sitagliptin (an Antihyperglycemic Drug) in 30 Patients With Type 2 Diabetes Mellitus (0431-178) [Phase 3]
This document reports the completion of a Phase 3 clinical trial evaluating sitagliptin in 30 patients with type 2 diabetes mellitus, with r…
-
CLINICAL_TRIALS trial_result · 2011-11-07Clinical Trial Update: VLDL-triglyceride Kinetics in Type 2 Diabetes
A completed clinical trial investigating the kinetics of VLDL-triglycerides in people with Type 2 diabetes mellitus. The snippet does not pr…
-
CLINICAL_TRIALS research · 2011-11-04Clinical Trial Update: Immune Profile and Complication Risk in Type 2 Diabetes
This clinical trial update investigates immune profiles and complication risk in adults with Type 2 diabetes. The current status of the stud…
-
CLINICAL_TRIALS trial_result · 2011-11-04Clinical Trial Update: n-3 Fatty Acid Infusion and Type 2 Diabetes [NA]
This clinical trial update indicates the study of an n-3 fatty acid infusion in individuals with Type 2 diabetes mellitus has been completed…
-
CLINICAL_TRIALS trial_result · 2011-11-03Clinical Trial Update: A Study of the Effects of Co-Administration of Sitagliptin (MK-0431) and Metformin on Incretin Hormone Concentrations (MK-0431-110) [Phase 1]
Phase 1 study evaluating the effects of co-administering sitagliptin and metformin on incretin hormone concentrations in type 2 diabetes; re…
-
CLINICAL_TRIALS trial_result · 2011-10-31Clinical Trial Update: Linagliptin 2.5 mg Twice Daily Versus 5 mg Once Daily as add-on Therapy to Twice Daily Metformin in Type 2 Diabetes [Phase 2]
This Phase 2 trial compared two dosing regimens of linagliptin (2.5 mg twice daily vs 5 mg once daily) as add-on therapy to metformin in adu…
-
FDA approval · 2011-10-30FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for insulin lispro from Eli Lilly, including the diluent, indicating regulatory approval of chan…
-
FDA approval · 2011-10-30FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMALOG MIX75/25 (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2011-10-30FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved Eli Lilly's supplemental application for Humalog Mix50/50 KwikPen (insulin lispro). The approval pertains to the Humalog Mix50/…
-
FDA approval · 2011-10-30FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin R (insulin human) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2011-10-28Clinical Trial Update: Safety and Tolerability Study of Cycloset in Treatment of Type 2 Diabetes [Phase 3]
Phase 3 safety and tolerability study of Cycloset for type 2 diabetes has completed and results have been posted.